Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEMUPLINT: Vemurafenib, Cobimetinib, and Peg-interferon in BRAF-Mutant Melanoma
NCT01959633Phase 2Completed
- Start
- Apr 2014
- Primary completion
- Mar 2018
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in melanoma. Started Apr 2014; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01959633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959633.